Description
OFF-MARKET ‘Q3 2024
IP W/Patent Manages At-Risk Patients’ Vital Signs
Chicago, Illinois (Cook County)
Seller financing: If the price and deal structure is right
Asking Price: Best Possible Offer
Cash Flow $350,000.00
Gross Revenue $985,000.00
EBITDA: N/A
FF&E: N/A
Inventory: See CIM
Established: 2000
Employees: 9
Business Description
Our client is offering a patented Intellectual Property to manage Real Time Vital Signs of at-risk patients, and to safely provide them to the Physicians, Nurses and other Primary Care Providers in underserved Rural and Urban Communities.
Our client has real world proof as provided first by an ongoing successful Pilot Program and subsequently, by actual current and ongoing implementation of the system in one of the largest Health Systems in the United States. Our client’s technology is primed to rapidly take over its targeted market.: major hospitals and health systems, as well as individual health services providers, to the great benefit of their chronically ill patients, especially important in underserved communities.
Services for customers include: Call Center Technical and Engineering Support, Comprehensive 24/7 Call Center Support, plus additional services to fully support provider and customer requirements. An Oracle Cerner Partner, our client has built integration into the electronic medical records that allows patient remote self-measures to flow directly into the patient medical record and patient portal.
RPM (Remote Patient Monitoring) devices allow physicians to be aware of a patient’s blood pressure, weight, temperature, blood oxygen, pulse rate, Electrocardiogram or glucose level without the patient having to come into an office or call in.
It is on the horizon for the Company to garner $10 million in revenues in 2023. The Seller indicates that “This is based on the great work we’ve already done and our current customer wanting to expand the program to north of 50,000 chronically ill patients over the next three (3) years”.
Our client’s current, existent contract value for 1,000 chronically ill patients, with a single major health care provider, is $985,000.
A five-year Projection assuming only the current client is served, indicates that nearly 80% of the investment of our client’s asking price would be recovered in 5 years. With a second client of similar size, the venture would already be more than profitable at five years, even considering the marketing and sales investment that would be needed.
An NDA is required to receive a comprehensive Confidential Information Memorandum (CIM) crafted by ProNova Partners.
Additional Details:
Financing:
If the price and deal structure is right
Support & Training:
Provided at no charge to enable a smooth transition
Reason for Selling:
Other Projects
Growth & Expansion:
In CIM, NDA Required.
Competition:
In CIM, NDA Required.